In the age of stickiest-of-ickiest-and-rising THC percentages, it appears the United States government still supplies researchers with low grade brick weed you probably smoked in high school. Actually, it’s worse than the weed you smoked in high school.  According to reports from PBS and the Washington Post, all marijuana used in research must be supplied […]

by

“It is exciting to see AXIM start on pre-clinical efforts alongside esteemed ophthalmology professionals to develop a cannabinoid based eye drop medication that may assist glaucoma sufferers,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. “This partnership between AXIM and Ora is another new exciting milestone for AXIM’s clinical development program, as it continues to […]

by

Kanabo Research, a Tel Aviv-based medical cannabis company, is aiming its vaporization formulations and devices at medical patients instead of the recreational users more commonly associated with vaporization. The company is closing its seed round funding and launching its initial product offerings at the CannaTech summit this week. Kanabo develops medical cannabis extracts meant to […]

by

TORONTO, ON–(Marketwired – March 21, 2017) – Delivra Corp. (TSX VENTURE: DVA) (“Delivra” or the “Company”), Dosecann Inc. (“Dosecann”) and ARA-Avanti Rx Analytics Inc. (“Avanti”) announced today a strategic partnership to develop a unique suite of standardized products for the medical cannabis research, development, and commercialization markets. “The Federal Government of Canada has numerous concerns, […]

by

Recent studies concerning the therapeutic attributes of Cannabidiol (CBD) have pointed to growing evidence to suggest that it could help in the treatment of anxiety-related and other health disorders. With recent research and development aimed at identifying new therapies and treatments for various ailments, companies are focusing on improving therapies such as: India Globalization Capital, Inc. […]

by

InMed’s drugs could generate $6 billion a year in revenue, but the company is also attracting attention for its cannabinoid database and biosynthesis manufacturing. (Shutterstock) InMed Pharmaceuticals is a Vancouver-based pre-clinical trial biotech company that has not only developed a proprietary cannabinoid manufacturing system but in the process created a highly sought after database. This […]

by

A bill that would allocate about $2.5 million for UF to research medical marijuana advanced in the Florida House of Representatives last week. The bill states that money from the General Revenue Fund will be used to fund UF’s research on the safety and efficiency of medical marijuana. The bill, which passed through the Health […]

by

Critics downplay the evidence for adding South Carolina to the 28 states that allow the use of medical marijuana, but even the nation’s most prestigious scientific association, the National Academy of Sciences, Engineering and Medicine, has concluded that cannabis is highly effective against chronic pain, chemotherapy-induced nausea and vomiting in cancer and multiple sclerosis patients. […]

by

Q-C Online: Moline and Rock Island, Illinois My Web Times: Ottawa and Streator, Illinois Post Bulletin: Rochester, Minnesota … read more at: http://www.daily-journal.com/opinion/editorials/good-science-on-marijuana-is-so-hard-to-find/article_2a674d5a-1d2d-5e83-9dbf-96ee7c8119ac.html

by

People taking psychoactive medications and drugs for conditions such as chronic pain tend to prefer medical cannabis to other drugs, including sedatives, opioids, and antidepressants, a study published in the International Journal of Drug Policy has found. Many analysts have expressed concerns about the use of opioids to treat chronic pain. More than 183,000… read more […]

by